Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy

Journal of the American Academy of Dermatology

Volumn 61, Issue 6, 2009, Pages 1070-1075

  Murota, Hiroyuki ^a   Shoda, Yukiko ^c   Ishibashi, Tomohiko ^c   Sugahara, Hiroyuki ^c   Matsumura, Itaru ^b   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c SUMITOMO HOSPITAL   (Japan)

Author keywords

B cell lymphoma; combination therapy; radiation; rituximab; Schnitzler syndrome

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; DAPSONE; FIBRINOGEN; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; SOLUBLE INTERLEUKIN 2 RECEPTOR;

AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; EOSINOPHIL; EOSINOPHILIA; FEMALE; FEVER; FIBRINOLYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LOW BACK PAIN; LYMPHOCYTIC INFILTRATION; MONOCLONAL IMMUNOGLOBULINEMIA; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RETROPERITONEAL TUMOR; SCHNITZLER SYNDROME; SKIN BIOPSY; SKIN EXAMINATION; SKIN MANIFESTATION; URTICARIA;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, B-CELL; RETROPERITONEAL NEOPLASMS; SCHNITZLER SYNDROME; URTICARIA;

EID: 71549165455     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.12.040     Document Type: Article

References (18)

1. Schnitzler L. Lésion urticariennes chroniques permanents (érythème pétaloide?). Case cliniques n. 46 B. J Dermatol Angers (1972) 28 (Abstr. 46)
2. Dalle S., Balme B., Sebban C., Pariset C., Berger F., and Thomas L. Schnitzler syndrome associated with systemic marginal zone B-cell lymphoma. Br J Dermatol 155 (2006) 827-829
3. Verret J.L., Leclech C., Rousselet M.C., Hurez D., and Schnitzler L. Schnitzler syndrome and Waldenström disease: fatal outcome of the original case. Ann Dermatol Venereol 120 (1993) 459-460
4. Govindaraju S., Brochot P., Ringot A.C., Paterrnotte L., Morrone A., Eschard J.P., et al. Chronic urticaria-macroglobulinemia (Schnitzler syndrome): developing to IgM myeloma; apropos of a case. Rev Med Interne 14 (1993) 780-783
5. Pujol R.M., Barrnadas M.A., Brunet S., and de Moragas J.M. Urticarial dermatosis associated with Waldenström's macroglobulinemia. J Am Acad Dermatol 20 (1989) 855-857
6. Lipsker D., Veran Y., Grunenberger F., Cribier B., Heid E., and Grosshans E. The Schnitzler syndrome: four new cases and review of the literature. Medicine (Baltimore) 80 (2001) 37-44
7. de Koning H.D., Bodar E.J., Van der Meer J.W., and Simon A. Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports; review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37 (2007) 137-148
8. Almerigogna F., Giudizi M.G., Cappelli F., and Romagnani S. Schnitzler's syndrome: what's new?. J Eur Acad Dermatol Venereol 16 (2002) 214-219
9. Kanazawa N., and Furukawa F. Autoinflammatory syndromes with a dermatological perspective. J Dermatol 34 (2007) 601-618
10. Olsen E., Forre O., Lea T., and Langerland T. Unique antigenic determinants (idiotypes) used as markers in a patient with macroglobulinemia and urticaria. Acta Med Scand 207 (1980) 379-384
11. Vijay A., and Gertz M.A. Waldenström macroglobulinemia. Blood 109 (2007) 5096-5103
12. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumors: pathology and genetics of tumors of hematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France
13. Canellos G.P., Lister T.A., and Young B. The lymphomas (2006), Saunders Elsevier Publishing
14. Petryk M., and Grossbard M.L. Rituximab therapy of B-cell neoplasms. Clin Lymphoma 1 (2000) 186-194
15. Boye J., Elter T., and Engert A. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 14 (2003) 520-535
16. Ramadan K.M., Eswedi H.A., and El-agnaf M.R. Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br J Dermatol 156 (2007) 1072-1073
17. Eiling E., Möller M., Kreiselmaier I., Brasch J., and Schwarz T. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol 57 (2007) 361-364
18. Westhoff T.H., Zidek W., Uharek L., Steinhoff-Georgieva J., and van der Giet M. Impairment of renal function in Schnitzler's syndrome. J Nephrol 19 (2006) 660-663